Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells

Kidney International

Volumn 56, Issue 6, 1999, Pages 2055-2063

  Amemiya, Tetsuro ^a   Sasamura, Hiroyuki ^a   Mifune, Mizuo ^a   Kitamura, Yudai ^a   Hirahashi, Junichi ^a   Hayashi, Matsuhiko ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Injury; Mesangial matrix; Mitogen activated protein kinase; VEGF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHELERYTHRINE; COLLAGEN; HERBIMYCIN A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SUPEROXIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GLOMERULUS; HORMONAL REGULATION; HUMAN; HUMAN CELL; MESANGIUM CELL; NONHUMAN; PHOSPHORYLATION; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033405953     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00796.x     Document Type: Article

References (29)

1. 1. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. EXS 79:233-269, 1997
2. 2. Dvorak HF, Detmar M, Claffey KP, Nagy JA, de Water LV, Senger DR: Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107:233-235, 1995
3. 3. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143:1255-1262, 1993
4. 4. Simon M, Groene H, Kullmer J, Plate KH, Risau W, Fuchs E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250, 1995
5. 125I)VEGF binding sites. J Am Soc Nephrol 9:1032-1044, 1998
6. 6. Klanke B, Simon M, Rockl W, Weich HA, Stolte H, Grone HJ: Effects of vascular endothelial growth factor (VEGF) vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney. Nephrol Dial Transplant 13:875-885, 1998
7. 7. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF: Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 7:661-666, 1996
8. 8. Takahashi T, Shirasawa T, Miyake K, Yahagi Y, Maruyama N, Kasahara N, Kawamura T, Matsumura O, Mitarai T, Sakai O: Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. Biochem Biophys Res Commun 209:218-226, 1995
9. 9. Trachtman H, Futterwett S, Franki N, Singhal PC: Effect of vascular endothelial growth factor on nitric oxide production by cultured rat mesangial cells. Biochem Biophys Res Commun 245:443-446, 1998
10. 10. Hirahashi J, Nakaki T, Hishikawa K, Marumo T, Yasumori T, Hayashi M, Suzuki H, Saruta T: Endothelin-1 inhibits induction of nitric oxide synthase and GTP cyclohydrolase I in rat mesangial cells. Pharmacology 53:241-249, 1996
11. 11. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
12. 12. Ahmed A, Dunk C, Kniss D, Wilkes M: Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76:779-791, 1997
13. 13. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135-147, 1995
14. 14. Markwell MA, Haas SM, Bieber LL, Tolbert NE: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206-210, 1978
15. 15. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T: Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 9:17-22, 1991
16. 16. Orth SR, Nobiling R, Boenisch S, Ritz E: Inhibitory effect of calcium channel blockers on human mesangial cell growth: Evidence for actions independent of L-type calcium channels. Kidney Int 49:868-879, 1996
17. 17. Hishikawa K, Oemar BS, Yang Z, Luescher TF: Pulsatile stretch stimulates superoxide production and activates nuclear factor-κB in human coronary smooth muscle. Circ Res 81:797-803, 1997
18. 18. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R: Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96:2361-2367, 1997
19. 19. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W: Vascular endothelial growth factor induces endothelial fenestrations in vivo. J Cell Biol 140:947-959, 1998
20. 20. Unemori EN, Ferrara N, Bauer EA, Amento EP: Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153:557-562, 1992
21. 21. Kitamoto Y, Tokunaga H, Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development. J Clin Invest 99:2351-2357, 1997
22. 22. Devries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991, 1992
23. 23. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Boehlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586, 1992
24. 24. Wheelerjones C, Abughazaleh R, Cospedal, R, Houliston RA, Martin J, Zachary I: Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via P42/P44 mitogen-activated protein kinase. FEBS Lett 420:28-32, 1997
25. 25. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54:775-784, 1998
26. 26. Iijima K, Yoshikawa N, Connolly DT, Nakamura H: Human mesangial cells and peripheral mononuclear cells produce vascular permeability factor. Kidney Int 44:959-966, 1993
27. 27. Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, Neufeld G, Shibuya M: A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 9:2683-2690, 1994
28. 28. Groene H, Simon M, Groene EF: Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 177:259-267, 1995
29. 29. Noguchi K, Yoshikawa N, Ito-Kariya S, Inoue Y, Hayashi Y, Ito H, Nakamura H, Iijima K: Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9:1815-1825, 1998